Proopiomelanocortin-derived peptides are synthesized and released by human keratinocytes

Journal of Clinical Investigation

Volumn 93, Issue 5, 1994, Pages 2258-2262

  Schauer, E ^a   Trautinger, F ^a   Kock A ^a   Schwarz, A ^a   Bhardwaj, R ^a   Simon, M ^a   Ansel, J C ^b   Schwarz, T ^a   Luger, T A ^a  

^a UNIVERSITY OF MÜNSTER   (Germany)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

cytokine; epidermis; inflammation; melanocyte stimulating hormone; proopiomelanocortin

Indexed keywords

ALPHA INTERMEDIN; CORTICOTROPIN; CYCLOPHILIN; CYTOKINE; PHORBOL 13 ACETATE 12 MYRISTATE; PROOPIOMELANOCORTIN; RECOMBINANT GAMMA INTERFERON; RECOMBINANT GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; RECOMBINANT INTERLEUKIN 1BETA; RECOMBINANT INTERLEUKIN 2; RECOMBINANT INTERLEUKIN 6; RECOMBINANT TUMOR NECROSIS FACTOR ALPHA; TRANSFORMING GROWTH FACTOR BETA;

ARTICLE; CARCINOMA CELL; CELL SECRETION; CELL STIMULATION; CONTROLLED STUDY; EPIDERMIS CELL; GEL PERMEATION CHROMATOGRAPHY; HORMONE SYNTHESIS; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; KERATINOCYTE; NORTHERN BLOTTING; PRIORITY JOURNAL; ULTRAVIOLET RADIATION;

EID: 0028219514     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI117224     Document Type: Article

References (30)

1. Eberle, A. N. 1988. The Melanotropins. Karger, Basel, Switzerland.
2. Burbach, J. P. H., and V. M. Wiegant. 1990. Gene expression, biosynthesis and processing of proopiomelanocortin peptides and vasopressin. In Neuropeptides: Basics and Perspectives. de Wied, editor. Elsevier, Amsterdam. 45-103.
3. Bateman, A., A. Singh, T. Kral, and S. Solomon. 1989. The immune-hypothalamic-pituitary-adrenal axis. Endocr. Rev. 10:92-112.
4. Tsong, S. D., D. Phillips, N. Halmi, A. S. Liotta, A. Margioris, C. W. Bardin, and D. T. Krieger. 1982. ACTH and beta-endorphin-related peptides are present in multiple sites in the reproductive tract of the male rat. Endocrinology. 110:2204-2206.
5. Lolait, S. J., J. A. Clements, A. J. Markwick, C. Cheng, M. McNally, A. I. Smith, and J. W. Funder. 1986. Pro-opiomelanocortin messenger ribonucleic acid and posttranslational processing of beta endorphin in spleen macrophages. J. Clin. Invest. 77:1776-1779.
6. Oates, E. L., G. P. Allaway, G. R. Armstrong, R. A. Boyajian, J. H. Kehrl, and B. S. Prabhakar. 1988. Human lymphocytes produce pro-opiomelanocortin gene-related transcripts. Effects of lymphotropic viruses. J. Biol. Chem. 263:10041-10044.
7. Thody, A. J., K. Ridley, R. J. Penny, R. Chalmers, C. Fisher, and S. Shuster. 1983. MSH peptides are present in mammalian skin. Peptides(NY). 4:813-816.
8. Nordlund, J. J., Z. A. Abdel Malek, R. E. Boissy, and L. A. Rheins. 1989. Pigment cell biology: an historical review. J. Invest. Dermatol. 92:53S-60S.
9. Brown, S. L., and J. E. Blalock. 1990. Neuroendocrine immune interactions. In Immunophysiology, the Role of Cells and Cytokines in Immunity and Inflammation. J. J. Oppenheim and E. M. Shevach, editors. Oxford University Press, Oxford, UK. 306-319.
10. Schwarz, T., and T. A. Luger. 1992. Pharmacology of cytokines in the skin. In Pharmacology of the Skin. H. Muhktar, editor. CRC Press, Boca Raton, FL. 283-314.
11. Kirnbauer, R., A. Kock, T. Schwarz, A. Urbanski, J. Krutmann, W. Borth, D. Damm, G. Shipley, J. C. Ansel, and T. A. Luger. 1989. IFN-beta 2, B cell differentiation factor 2, or hybridoma growth factor (IL-6) is expressed and released by human epidermal cells and epidermoid carcinoma cell lines. J. Immunol. 142:1922-1928.
12. Schwarz, T., A. Urbanska, F. Gschnait, and T. A. Luger. 1987. UV-irradiated epidermal cells produce a specific inhibitor of interleukin 1 activity. J. Immunol. 138:1457-1463.
13. Catania, A., L. Airaghi, M. G. Manfredi, M. C. Vivirito, F. Milazzo, J. M. Lipton, and C. Zanussi. 1993. Proopiomelanocortin-derived peptides and cytokines: relations in patients with acquired immunodeficiency syndrome. Clin. Immunol. Immunopathol. 66:73-79.
14. Pomeranz, S. H. 1966. The tyrosine hydroxylase activity of mammalian tyrosinase. J. Biol. Chem. 241:161-168.
15. Gieselmann, V., R. Pohlmann, A. Hasilik, and K. Figura. 1983. Biosynthesis and transport of cathepsin D in cultured human fibroblasts. J. Cell Biol. 97:1-7.
16. Laemmli, U. K. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (Lond.). 227:680-683.
17. Feinberg, A. P., and P. A. Vogelstein. 1983. A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity. Anal. Biochem. 132:6-13.
18. Kupper, T. 1990. The role of epidermal cytokines. In Immunophysiology, the role of Cells and Cytokines in Immunity and Inflammation. J. J. Oppenheim and E. M. Shevach, editors. Oxford University Press, New York. 285-305.
19. Schwarz, T., A. Urbanski, F. Gschnait, and T. A. Luger. 1986. Inhibition of the induction of contact hypersensitivity by a UV-mediated epidermal cytokine. J. Invest. Dermatol. 87:289-291.
20. Pawelek, J. M. 1990. Is human melanogenesis stimulated by cyclic AMP? J. Invest. Dermatol. 94:499-500.
21. Burchill, S. A., J. M. Marks, and A. J. Thody. 1990. Tyrosinase synthesis in different skin types and the effects of alpha-melanocyte-stimulating hormone and cyclic AMP. J. Invest. Dermatol. 95:558-561.
22. Pears, R. S., R. T. Jung, W. Bartlett, M. C. K. Browning, K. Kenicer, and A. J. Thody. 1992. A case of skin hyperpigmentation due to alpha-MSH hypersecretion. Br. J. Dermatol. 126:286-289.
23. Lerner, A. B., and J. S. McGuire. 1961. The effect of alpha and beta melanocyte stimulating hormone on the skin colour of man. Nature (Lond.). 189:176-179.
24. Levine, N., S. N. Sheftel, T. Eytan, R. T. Dorr, M. E. Hadley, J. C. Weinrach, G. A. Ertl, K. Toth, D. L. McGee, and V. J. Hruby. 1991. Induction of skin tanning by subcutaneous administration of a potent synthetic melanotropin. JAMA (J. Am. Med. Assoc.). 266:2730-2736.
25. Cannon, J. G., J. B. Tatro, S. Reichlin, and C. A. Dinarello. 1986. Alpha melanocyte stimulating hormone inhibits immunostimulatory and inflammatory actions of interleukin 1. J. Immunol. 137:2232-2236.
26. Robertson, B., K. Dostal, and R. A. Daynes. 1988. Neuropeptide regulation of inflammatory and immunologic responses. The capacity of alpha-melanocyte-stimulating hormone to inhibit tumor necrosis factor and IL-1-inducible biologic responses. J. Immunol. 140:4300-4307.
27. Aebischer, I., E. Schauer, A. Schwarz, T. Schwarz, B. M. Stadler, and T. A. Luger. 1993. Regulation of IgE production and interferon gamma synthesis by proopiomelanocortin derived peptides. J. Invest. Dermatol. 100:574. (Abstr.)
28. Bhardwaj, R. S., A. Schwarz, Y. Aragane, M. Simon, A. Palmetshofer, H. Riemann, M. Hartmeyer, T. Schwarz, and T. A. Luger. 1994. Alpha-melanocyte stimulating hormone augments interleukin 10 production by human T cells. Arch. Dermatol. Res. 286:229. (Abstr.)
29. Rheins, L. A., A. L. Cotleur, R. S. Kleier, W. B. Hoppenjans, D. N. Sauder, and J. J. Nordlund. 1989. Alpha-melanocyte stimulating hormone modulates contact hypersensitivity responsiveness in C57/BL6 mice. J. Invest. Dermatol. 93:511-517.
30. Jessup, J. M., N. Hanna, E. Palaszynski, and M. L. Kripke. 1978. Mechanisms of depressed reactivity to dinitrochlorobenzene and ultraviolet-induced tumors during ultraviolet carcinogenesis in BALB/c mice. Cell. Immunol. 38:105-115.